Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 17.9B | 15.0B | 15.1B | 15.9B |
Cost of revenue | 9.3B | 7.7B | 7.8B | 8.0B |
Gross profit | 8.6B | 7.3B | 7.3B | 7.9B |
Operating expense | ||||
Research & development | 304M | 296M | 252M | 258M |
Selling general and admin | 707M | 343M | 346M | 475M |
Other operating expenses | 777M | 884M | 851M | 779M |
Operating income | 3.5B | 3.4B | 3.3B | 4.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 4.0B | 3.2B | 2.6B | 4.1B |
Tax provision | 1.3B | 1.1B | 475M | 1.3B |
Net income | 2.7B | 2.2B | 2.1B | 2.8B |
Basic EPS | — | 24.7 | — | — |
Diluted EPS | — | 24.7 | — | — |
Basic average shares | — | 88.6M | — | — |
Diluted average shares | — | 88.6M | — | — |
EBITDA | 4.3B | 3.6B | 4.4B | 4.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |